🇺🇸 FDA
Pipeline program

cyclobenzaprine hydrochloride

CEPH03242010

Phase 3 small_molecule terminated

Quick answer

cyclobenzaprine hydrochloride for Chronic Migraine is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Chronic Migraine
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials